La fabrication d’un vaccin, un processus très encadré

The development of a vaccine requires a very high level of expertise. It is a long and complex process. But in the fight against Covid-19, exceptional research and regulatory efforts have been made to successfully deliver a vaccine solution in less than a year.

Detalles Bibliográficos
Autor principal: Blin, Aurore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101018/
https://www.ncbi.nlm.nih.gov/pubmed/33972812
http://dx.doi.org/10.1016/j.actpha.2021.03.019
_version_ 1783688891575828480
author Blin, Aurore
author_facet Blin, Aurore
author_sort Blin, Aurore
collection PubMed
description The development of a vaccine requires a very high level of expertise. It is a long and complex process. But in the fight against Covid-19, exceptional research and regulatory efforts have been made to successfully deliver a vaccine solution in less than a year.
format Online
Article
Text
id pubmed-8101018
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-81010182021-05-06 La fabrication d’un vaccin, un processus très encadré Blin, Aurore Actual Pharm Article The development of a vaccine requires a very high level of expertise. It is a long and complex process. But in the fight against Covid-19, exceptional research and regulatory efforts have been made to successfully deliver a vaccine solution in less than a year. Elsevier Masson SAS. 2021-05 2021-05-06 /pmc/articles/PMC8101018/ /pubmed/33972812 http://dx.doi.org/10.1016/j.actpha.2021.03.019 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Blin, Aurore
La fabrication d’un vaccin, un processus très encadré
title La fabrication d’un vaccin, un processus très encadré
title_full La fabrication d’un vaccin, un processus très encadré
title_fullStr La fabrication d’un vaccin, un processus très encadré
title_full_unstemmed La fabrication d’un vaccin, un processus très encadré
title_short La fabrication d’un vaccin, un processus très encadré
title_sort la fabrication d’un vaccin, un processus très encadré
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101018/
https://www.ncbi.nlm.nih.gov/pubmed/33972812
http://dx.doi.org/10.1016/j.actpha.2021.03.019
work_keys_str_mv AT blinaurore lafabricationdunvaccinunprocessustresencadre

Ejemplares similares